Good morning :)
Place Order
Add to Watchlist

3B Blackbio DX Ltd

3BBLACKBIO Share Price

1,466.600.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Biotechnology
Smallcap

With a market cap of ₹1,258 cr, stock is ranked 1,353

High Risk

Stock is 4.48x as volatile as Nifty

3BBLACKBIO Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care
Biotechnology
Smallcap

With a market cap of ₹1,258 cr, stock is ranked 1,353

High Risk

Stock is 4.48x as volatile as Nifty

3BBLACKBIO Performance & Key Metrics

3BBLACKBIO Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
26.445.58—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.486.570.80%

3BBLACKBIO Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

3BBLACKBIO Company Profile

3B Blackbio DX Ltd specializes in PCR-based molecular diagnostic kits, offering a range of products for oncology, infectious diseases, and human genetics, serving diagnostics labs across India.

3BBLACKBIO Similar Stocks (Peers)

Compare with peers Compare with peers 

3BBLACKBIO Similar Stocks (Peers)

Compare with peers Compare with peers 
Biocon Ltd
BIOCON
PE Ratio
47.74
47.74
1Y Return
1.36%
1.36%
Buy Reco %
73.33
73.33
Onesource Specialty Pharma Ltd
ONESOURCE
PE Ratio
-1,351.03
-1,351.03
1Y Return
23.96%
23.96%
Buy Reco %
100.00
100.00
Sai Life Sciences Ltd
SAILIFE
PE Ratio
95.58
95.58
1Y Return
1.98%
1.98%
Buy Reco %
66.67
66.67
Acutaas Chemicals Ltd
ACUTAAS
PE Ratio
57.87
57.87
1Y Return
70.26%
70.26%
Buy Reco %
100.00
100.00
Panacea Biotec Ltd
PANACEABIO
PE Ratio
-300.44
-300.44
1Y Return
204.27%
204.27%
Buy Reco %
0.00
0.00
Compare with Peers

3BBLACKBIO Forecast

3BBLACKBIO Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

3BBLACKBIO

3BBLACKBIO

Income

Balance Sheet

Cash Flow

3BBLACKBIO Income Statement

3BBLACKBIO Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 29.63%, vs industry avg of 21.18%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.36% to 0.51%

Higher than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 44.06%, vs industry avg of 20.36%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue16.4323.4924.0230.47229.6387.5569.1086.65111.55111.56
Raw Materialssubtract8.630.000.000.000.311.0318.3321.5446.3646.35
Power & Fuel Costsubtract0.190.200.180.200.240.230.240.22
Employee Costsubtract2.022.112.532.854.673.815.036.50
Selling & Administrative Expensessubtract1.271.181.061.515.853.263.763.54
Operating & Other expensessubtract1.4914.3012.2915.0065.6835.225.369.34
Depreciation/Amortizationsubtract0.450.460.550.540.620.670.861.061.091.09
Interest & Other Itemssubtract0.980.730.460.330.230.110.200.120.110.10
Taxes & Other Itemssubtract0.271.091.712.3638.1711.039.3712.2316.3416.42
EPS1.775.368.1911.04151.6542.8732.2537.4055.6655.46
DPS0.300.500.500.709.0010.502.503.000.003.00
Payout ratio0.170.090.060.060.060.240.080.080.000.05
See Costs

3BBLACKBIO Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF

Investor Presentation

Jul 29PDF
FY 2021FY 2021

Annual report

PDF

Investor Presentation

Jun 23PDF
Nov 5PDF
Sep 17PDF
Jul 31PDF
FY 2020FY 2020

Annual report

PDF

Investor Presentation

Jun 26PDF
Feb 11PDF
Nov 11PDF
Jul 29PDF
FY 2019FY 2019

Annual report

PDF

Investor Presentation

May 23PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
 

3BBLACKBIO Stock Peers

3BBLACKBIO Past Performance & Peer Comparison

3BBLACKBIO Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareBiotechnology

Valuation

Technical

Forecast

ScreenerCompare valuation-basic on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
3B Blackbio DX Ltd26.425.58—
Biocon Ltd47.741.910.31%
Onesource Specialty Pharma Ltd-1,351.0361.32—
Sai Life Sciences Ltd95.5816.68—

3BBLACKBIO Stock Price Comparison

Compare 3BBLACKBIO with any stock or ETF
Compare 3BBLACKBIO with any stock or ETF
3BBLACKBIO
Loading...

3BBLACKBIO Holdings

3BBLACKBIO Shareholdings

3BBLACKBIO Promoter Holdings Trend

3BBLACKBIO Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

3BBLACKBIO Institutional Holdings Trend

3BBLACKBIO Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

3BBLACKBIO Shareholding Pattern

3BBLACKBIO Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding41.28%0.00%1.60%2.49%54.63%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

3BBLACKBIO Shareholding History

3BBLACKBIO Shareholding History

FebMarJunSepDec '24Mar2.97%2.97%3.28%3.27%2.68%2.49%

3BBLACKBIO Insider Trades & Bulk Stock Deals

3BBLACKBIO Insider Trades & Bulk Stock Deals

Loading...

smallcases containing 3BBLACKBIO stock

smallcases containing 3BBLACKBIO stock

Looks like this stock is not in any smallcase yet.

3BBLACKBIO Events

3BBLACKBIO Events

3BBLACKBIO Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

3BBLACKBIO Dividend Trend

No dividend trend available

3BBLACKBIO Upcoming Dividends

3BBLACKBIO Upcoming Dividends

No upcoming dividends are available

3BBLACKBIO Past Dividends

3BBLACKBIO Past Dividends

Cash Dividend

Ex DateEx DateSep 17, 2024

Final
Final | Div/Share: ₹3.00

Dividend/Share

₹3.00

Ex DateEx Date

Sep 17, 2024

Cash Dividend

Ex DateEx DateSep 15, 2023

Final
Final | Div/Share: ₹2.50

Dividend/Share

₹2.50

Ex DateEx Date

Sep 15, 2023

Cash Dividend

Ex DateEx DateSep 14, 2022

Final
Final | Div/Share: ₹2.50

Dividend/Share

₹2.50

Ex DateEx Date

Sep 14, 2022

Cash Dividend

Ex DateEx DateSep 14, 2021

Special
Special | Div/Share: ₹8.00

Dividend/Share

₹8.00

Ex DateEx Date

Sep 14, 2021

Cash Dividend

Ex DateEx DateSep 14, 2021

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Sep 14, 2021

3BBLACKBIO Stock News & Opinions

3BBLACKBIO Stock News & Opinions

Spotlight
3B Blackbio DX Ltd leads losers in 'B' group

Denta Water & Infra Solutions Ltd, Delta Manufacturing Ltd, Alpa Laboratories Ltd and Ashoka Metcast Ltd are among the other losers in the BSE's 'B' group today, 29 May 2025.3B Blackbio DX Ltd crashed 15.76% to Rs 1593.95 at 14:31 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 64484 shares were traded on the counter so far as against the average daily volumes of 5986 shares in the past one month.Denta Water & Infra Solutions Ltd tumbled 10.06% to Rs 282.1. The stock was the second biggest loser in 'B' group.On the BSE, 2.24 lakh shares were traded on the counter so far as against the average daily volumes of 31928 shares in the past one month.Delta Manufacturing Ltd lost 10.00% to Rs 88.42. The stock was the third biggest loser in 'B' group.On the BSE, 7938 shares were traded on the counter so far as against the average daily volumes of 6462 shares in the past one month.Alpa Laboratories Ltd plummeted 9.05% to Rs 105.05. The stock was the fourth biggest loser in 'B' group.On the BSE, 14557 shares were traded on the counter so far as against the average daily volumes of 4563 shares in the past one month.Ashoka Metcast Ltd slipped 8.55% to Rs 17.75. The stock was the fifth biggest loser in 'B' group.On the BSE, 1.08 lakh shares were traded on the counter so far as against the average daily volumes of 8313 shares in the past one month.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Board of 3D Blackbio DX recommends final dividend

3D Blackbio DX announced that the Board of Directors of the Company at its meeting held on 28 May 2025, inter alia, have recommended the final dividend of Rs 4 per equity Share (i.e. 40%) , subject to the approval of the shareholders.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
3B Blackbio DX consolidated net profit declines 5.30% in the March 2025 quarter

Net profit of 3B Blackbio DX declined 5.30% to Rs 8.40 crore in the quarter ended March 2025 as against Rs 8.87 crore during the previous quarter ended March 2024. Sales declined 2.17% to Rs 22.50 crore in the quarter ended March 2025 as against Rs 23.00 crore during the previous quarter ended March 2024. For the full year,net profit rose 45.59% to Rs 47.65 crore in the year ended March 2025 as against Rs 32.73 crore during the previous year ended March 2024. Sales rose 30.15% to Rs 96.47 crore in the year ended March 2025 as against Rs 74.12 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales22.5023.00 -2 96.4774.12 30 OPM %35.2042.96 -51.9444.50 - PBDT12.8214.03 -9 65.0845.39 43 PBT12.5413.73 -9 64.0044.33 44 NP8.408.87 -5 47.6532.73 46 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
3D Blackbio DX to hold board meeting

3D Blackbio DX will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
3B Blackbio DX consolidated net profit rises 53.67% in the December 2024 quarter

Net profit of 3B Blackbio DX rose 53.67% to Rs 13.40 crore in the quarter ended December 2024 as against Rs 8.72 crore during the previous quarter ended December 2023. Sales rose 43.69% to Rs 25.39 crore in the quarter ended December 2024 as against Rs 17.67 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales25.3917.67 44 OPM %59.3950.20 - PBDT18.0611.47 57 PBT17.8011.15 60 NP13.408.72 54 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
3D Blackbio DX to conduct board meeting

3D Blackbio DX will hold a meeting of the Board of Directors of the Company on 13 February 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
3B Blackbio DX consolidated net profit rises 86.62% in the September 2024 quarter

Net profit of 3B Blackbio DX rose 86.62% to Rs 14.65 crore in the quarter ended September 2024 as against Rs 7.85 crore during the previous quarter ended September 2023. Sales rose 51.98% to Rs 29.15 crore in the quarter ended September 2024 as against Rs 19.18 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales29.1519.18 52 OPM %55.4740.62 - PBDT19.5810.50 86 PBT19.3110.26 88 NP14.657.85 87 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
3D Blackbio DX announces board meeting date

3D Blackbio DX will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
3D Blackbio DX schedules AGM

3D Blackbio DX announced that the Annual General Meeting (AGM) of the company will be held on 24 September 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live
Corporate
3D Blackbio DX to hold AGM

3D Blackbio DX announced that the Annual General Meeting (AGM) of the company will be held on 24 September 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of 3B Blackbio DX Ltd (3BBLACKBIO) today?

    The share price of 3BBLACKBIO as on 1st July 2025 is ₹1466.60. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on 3B Blackbio DX Ltd (3BBLACKBIO) share?

    The past returns of 3B Blackbio DX Ltd (3BBLACKBIO) share are
    • Past 1 week: 1.22%
    • Past 1 month: -13.35%
    • Past 3 months: -12.41%
    • Past 6 months: -24.34%
    • Past 1 year: 26.38%
    • Past 3 years: 371.35%
    • Past 5 years: 667.85%

  3. What are the peers or stocks similar to 3B Blackbio DX Ltd (3BBLACKBIO)?

    The peers or stocks similar to 3B Blackbio DX Ltd (3BBLACKBIO) include:

  4. What is the market cap of 3B Blackbio DX Ltd (3BBLACKBIO) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of 3B Blackbio DX Ltd (3BBLACKBIO) is ₹1258.73 Cr as of 1st July 2025.

  5. What is the 52 week high and low of 3B Blackbio DX Ltd (3BBLACKBIO) share?

    The 52-week high of 3B Blackbio DX Ltd (3BBLACKBIO) is ₹2350 and the 52-week low is ₹990.

  6. What is the PE and PB ratio of 3B Blackbio DX Ltd (3BBLACKBIO) stock?

    The P/E (price-to-earnings) ratio of 3B Blackbio DX Ltd (3BBLACKBIO) is 26.42. The P/B (price-to-book) ratio is 5.58.

  7. Which sector does 3B Blackbio DX Ltd (3BBLACKBIO) belong to?

    3B Blackbio DX Ltd (3BBLACKBIO) belongs to the Health Care sector & Biotechnology sub-sector.

  8. How to buy 3B Blackbio DX Ltd (3BBLACKBIO) shares?

    You can directly buy 3B Blackbio DX Ltd (3BBLACKBIO) shares on Tickertape. Simply sign up, connect your demat account and place your order.